1. Home
  2. MTRN vs TVTX Comparison

MTRN vs TVTX Comparison

Compare MTRN & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Materion Corporation

MTRN

Materion Corporation

HOLD

Current Price

$221.54

Market Cap

5.5B

Sector

Industrials

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$50.31

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTRN
TVTX
Founded
1931
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.3B
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
MTRN
TVTX
Price
$221.54
$50.31
Analyst Decision
Buy
Strong Buy
Analyst Count
5
15
Target Price
★ $303.75
$75.21
AVG Volume (30 Days)
218.8K
★ 1.5M
Earning Date
11-04-2026
11-06-2026
Dividend Yield
★ 0.26%
N/A
EPS Growth
★ 1178.57
92.89
EPS
★ 2.76
N/A
Revenue
N/A
N/A
Revenue This Year
$33.41
$47.65
Revenue Next Year
$9.16
$49.39
P/E Ratio
$79.68
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$109.61
$22.59
52 Week High
$324.99
$68.73

Technical Indicators

Market Signals
Indicator
MTRN
TVTX
Relative Strength Index (RSI) 35.18 32.97
Support Level $191.03 $49.46
Resistance Level $260.28 $59.93
Average True Range (ATR) 14.26 2.29
MACD -6.95 0.04
Stochastic Oscillator 8.01 6.55

Price Performance

Historical Comparison
MTRN
TVTX

About MTRN Materion Corporation

Materion Corp offers products that include precious and non-precious specialty metals, inorganic chemicals and powders, specialty coatings, specialty engineered beryllium and copper-based alloys, beryllium composites, ceramics, and engineered clad and plated metal systems. Its segments are: Performance Materials provides beryllium and non-beryllium containing alloy systems and custom engineered parts. Electronic Materials produces chemicals, microelectronics packaging, and specialty metal products, including vapor deposition targets and preforms. Precision Optics produces thin film coatings and optical filter materials. The Other reportable segment includes unallocated corporate costs and assets. It operates in the United States, Asia, Europe, and other countries.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: